Jon Jones mocked Daniel Cormier about steroid allegations prior to UFC 214 and now he is facing a drug suspension
Sean M. Haffey/Getty Images
The UFC has confirmed that Jon Jones is being investigated for a failed drug test on the night of his UFC 214 win over Daniel Cormier in which Jones reclaimed the light heavyweight title belt.
According to TMZ, Jones tested positive for Turinabol, an anabolic steroid and that he could be suspended for up to four years.
This would be the second time Jones has tested positive for steroids surrounding a UFC fight, following UFC 200 in 2016 in which he was pulled from the card just three days prior to the event. However, that is only part of the irony of his latest link to steroids.
Prior to UFC 214, Jones mocked Cormier on Twitter about previous steroid allegations, wondering aloud, "wonder what his excuse will be this time."
"Daniel says the only reason I defeated him the first time is because I must have been on steroids," Jones wrote on Twitter in July. "Wonder what his excuse will be this time."
Ouch. As Darren Rovell of ESPN noted, that tweet did not age well.
Daniel says the only reason I defeated him the first time is because I must have been on steroids, wonder what his excuse will be this time pic.twitter.com/HMCFQBoBR4
- Jon Bones Jones (@JonnyBones) July 21, 2017
- Thailand is now welcoming Indians with open arms, but are its drought-hit islands really prepared for a tourism influx?
- Thoughtful gift ideas to make Mother's Day extra special
- Muslims up, Hindus down: What’s the larger picture behind India’s religious population trends?
- Scooch over magic mushrooms, toad venom could be the next big psychedelic for depression and anxiety!
- TBO Tek IPO allotment – How to check allotment, GMP, listing date and more
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market